PHARMA TECHNOLOGY A/S: Financial statements 2014
CVR: 20826746
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PHARMA TECHNOLOGY A/S (CVR 20826746) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 24,461,556 and a net result of DKK 4,567,583 compared with DKK 3,566,626 the year before. The profit margin was 18.7%. Equity in the 2014 report amounted to DKK 5,067,583. The solvency ratio was 54.5%. The company had 11 employees in the financial year.
- Revenue
- DKK 24,461,556
- Gross Profit
- DKK 14,760,783
- Profit/Loss
- DKK 4,567,583
- Equity
- DKK 5,067,583
- Total Assets
- DKK 9,292,468
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 24.5 mio. | 14.8 mio. | 4.6 mio. | 5.1 mio. | 11 |
| 2013 | - | 12.8 mio. | 3.6 mio. | 4.1 mio. | - |
| 2012 | - | 6 mio. | 1.4 mio. | 1.9 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMA TECHNOLOGY A/S has published its annual report for 2013. Gross profit came to DKK 12,826,166, and the net result was DKK 3,566,626.
As of May 21, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of May 21, 2014, Sønderup I/S, statsautoriserede revisorer has stepped down as auditor of PHARMA TECHNOLOGY A/S.
About PHARMA TECHNOLOGY A/S
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.